Skip to main content
. 2020 Jun 22;12(12):12019–12031. doi: 10.18632/aging.103367

Table 1. Demographic characteristics and neuropsychological test of all sample participants.

APOEε4 carriers (n=129) APOEε4 noncarriers (n=717) Main APOEε4 effect Main age effect Age×APOE ε4 interaction
Male/Female 47/82 264/453 1a
Age (years) 64.90±7.39 65.18±7.34 0.69
Education (years) 11.08±3.61 10.82±3.67 0.47
MCI (Y/N) 23/106 97/620 0.22 a
Hypertension (%) 51 (39.5%) 296 (41%) 0.83 a
Hyperlipidemia (%) 69(53.4%) 327 (45.6%) 0.205 a
Diabetes (%) 12 (9.3%) 116 (16.2%) 0.107 a
Coronary heart disease (%) 7 (5.4%) 82 (11.4%) 0.112 a
Cerebrovascular disease (%) 15 (11.6%) 86 (12%) 1 a
Family history of dementia (%) 3 (2.3%) 10 (13.9%) 0.332 a
MMSE 27.29±2.25 27.66±1.96 0.001 <0.0001 0.011
Memory -0.069±0.75 0.012±0.74 0.063 <0.0001 0.144
Visuo-spatial ability -0.053±0.91 0.003±0.84 0.383 0.003 0.006
Attention -0.054±0.74 0.001±0.79 0.051 <0.0001 0.300
Language -0.009±0.89 -0.001±0.82 0.143 <0.0001 0.028
Executive function -0.046±0.85 -0.003±0.83 0.292 <0.0001 0.184

Values are mean±standard deviation or Nos. of participants.

aThe p-value for sex and MCI status were obtained using χ2 test.